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Abstract
Primary hyperparathyroidism (PHP) in children is a rare condition and has a very dynamic course with nonspecific symptoms, what 
complicates the diagnosis and delays PHP treatment. 
Case presentation: A 15-year-old boy was admitted to the Orthopedic Ward with the diagnosis of juvenile bilateral slipped capital 
femoral epiphysis and valgus deformities. Gait disturbances, limb pains and valgus knee deformities, polyuria, polydipsia and weight 
loss, have been increasing for 8 months. Despite the hypercalcemia found in laboratory tests and bone destruction demonstrated in 
computed tomography of the hips, orthopedic correction was performed. In histopathological examination -brown bone tumors. The 
PTH concentration was determined (PTH – 589.1 pg/ml; (N: 10–60) and the child was referred to the Department of Pediatric En-
docrinology, where severe hypercalcemia (Ca – 4.07 mmol/l, N: 2.2–2.84) and hypophosphatemia (P – 0.68 mmol/l; N: 0.95–1.75) 
and adenoma of the left lower parathyroid gland was diagnosed. Forced diuresis, loop diuretics and pamidronic acid were used to 
obtain normocalcemia. The complications of hypercalcemia were excluded; diagnostic management excluding multiple endocrine 
neoplasia type 1 and 2a (MEN 1 and MEN 2A) syndrome were performed. The child was referred to the Department of Endocrino-
logical Surgery, where the adenoma of the left inferior parathyroid gland was resected. 
Conclusions: 1) Patients with PHP should be diagnosed of the condition based on clinical symptoms. In patients with specific symp-
toms, it is necessary to determine serum Ca levels, especially prior to the surgical procedures. 2) In each case of PHP, determinations 
should be made of blood PTH, Ca and P and detection of MEN 1 and MEN 2A syndromes. 3) Patients with hyperparathyroidism 
require management of multiorgan complications of hypercalcemia. 4) Following surgical treatment of parathyroid adenoma, long-
term endocrinological follow-up is necessary.
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Streszczenie
Pierwotna nadczynność przytarczyc (primary hyperparathyroidism – PHP) u dzieci jest rzadkim schorzeniem o burzliwym przebiegu 
i nietypowych objawach, co utrudnia rozpoznanie i opóźnia leczenie. 
Prezentacja przypadku: Chłopiec, lat 15, został przyjęty na Oddział Ortopedii z rozpoznaniem obustronnego złuszczenia głowy 
kości udowej oraz koślawości kończyn dolnych. Zaburzenia chodu, bóle i deformacje kończyn obserwowano od 5 miesięcy, po-
lidypsję, poliurię i utratę masy ciała od 8 miesięcy. Mimo hiperkalcemii stwierdzonej w badaniach laboratoryjnych oraz destrukcji 
kości, którą wykazała tomografia komputerowa bioder, wykonano zabieg ortopedyczny. W badaniu histopatologicznym stwierdzono 
guzy brunatne kości. Stężenie PTH – 589.1 pg/ml; (N: 10–60). Pacjenta skierowano na Oddział Endokrynologii Dziecięcej, gdzie 
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Introduction
Primary hyperparathyroidism (PHP) is a condition that is ex-
ceptionally rare in developmental age, its incidence in children 
is 2–5/100,000 [1–5]. Hyperparathyroidism is a  complex of 
clinical symptoms where the predominating element is hyper-
calcemia resulting from excessive PTH production [6]. Primary 
hyperparathyroidism may be an isolated condition or a compo-
nent of various syndromes, e.g. MEN 1, 2A and 4; it also may be 
sporadic or familial. Development of PHP has been associated 
with numerous germinal and somatic mutation of genes such 
as MEN1, RET, CDKN1B, PRAD1, HRPT2, HRPT3 [7–9]. In the 
majority of cases, PHP is a consequence of adenoma involv-
ing one parathyroid gland, only in 3% of cases it results from 
multiple adenomas [3, 6]. Clinical symptoms of PHP usually 
involve the skeletal, urinary, gastrointestinal, neuromuscular, 
and cardio-vascular system; abnormalities are also detected 
in the organ of vision [3, 4, 6, 10]. In adults, as many as 80% of 
patients with PHP are asymptomatic, while in children the con-
dition has a very dynamic course, oftentimes with nonspecific 
symptoms, what renders the diagnosis markedly difficult and 
delays PHP treatment [5].
Case presentation
A 15-year-old boy was admitted to the Orthopedic Ward, 
University Children’s Hospital of Krakow, with the diagnosis of 
juvenile bilateral slipped capital femoral epiphysis and valgus 
deformities involving both lower extremities, especially on the 
left side. Gait disturbances, limb pains and valgus knee deformi-
ties, have been increasing for 5 months, polyuria, polydipsia and 
weight loss have been increasing 8 months. After 6 months the 
boy was consulted by an orthopedic surgeon. At the same time, 
tests performed in his local health care facility demonstrated hy-
percalcemia (Ca – 3.15 N: 2.10–2.55), which was not taken into 
consideration in diagnostic management of bone lesions. De-
spite those contraindications, the surgical procedure has been 
planned. CT of the hips demonstrated bone destruction with pre-
dominating bilateral lytic lesions, numerous osteolytic foci vary-
ing in size and involving the proximal ends of the femurs. The 
patient presented with a single lytic focus in the inferior-anterior 
zone of the left iliac, 22 × 12 × 25 mm in size, joint space nar-
rowing involving both hip joints, soft tissue thickening and exu-
dation in the hip joints (Fig. 1). Bone scintiscan with 99mTc-Methyl 
diphosphonate (Tc99m-MDP) was performed and demonstrated 
an enhanced uptake in the long bone epiphyses, ribs and flat 
bones. After 8 months the boy underwent nailing in situ of the 
slipped capital right femoral epiphysis, subcapital osteotomy of 
the left femoral bone and osteotomy of the distal left femoral 
epiphysis aiming at removing valgus-associated lesions. Histo-
pathology of the material collected from the femoral neck dem-
onstrated ambiguous lesions that might have corresponded 
to giant cell reparative granuloma, brown tumor and giant cell 
tumor. Following determination of the PTH level – 589.1 pg/ml; 
(N: 10–60 pg/ml), the boy was referred to the Endocrinology 
Outpatient Department, University Children’s Hospital of Cra-
cow. The boy walked on crutches; apart from bone pain, he 
reported poorer appetite, constipation, polyuria, polydipsia and 
body weight loss of approximately 10 kg in the past year (Fig. 2). 
His family history was negative with respect to PHP and multiple 
endocrine neoplasia (MEN) syndromes. Physical examination 
demonstrated good general condition, his height was 169, 2 cm 
(–0,35 z-score standard WHO growth charts), weight 53 kg, 
10% body mass deficit, body mass index 18,77 kg/m2, (–0.10 
z-score standard WHO growth charts), heart rate of 120/min, 
arterial pressure of 140/80 mm Hg, acne lesions on the face, 
surgical scars in the iliac region and left thigh, puberty at Tanner 
stage V (Fig. 3). Out-patient tests showed hypercalcemia (Ca – 
4.07 mmol/l, N: 2.2–2.84) and hypophosphatemia (P – 0.68 
mmol/l; N: 0.95–1.75). Ultrasound detected a hyperechogenic 
area measuring 1.5 × 2.05 cm in the inferior left thyroid pole 
stwierdzono ciężką hiperkalcemię (Ca c. – 4.07 mmol/l; N: 2.2–2.84), hipofosfatemię (P – 0.68 mmol/l; N: 0.95–1.75). Rozpoznano 
gruczolaka lewej, dolnej przytarczycy. Po zastosowaniu forsowanej diurezy, diuretyków pętlowych i kwasu pamidronowego uzyskano 
normokalcemię. Wykluczono powikłania hiperkalcemii oraz zespoły MEN 1 i MEN 2A. Na Oddziale Chirurgii Endokrynologicznej 
usunięto gruczolaka przytarczyc. 
Wnioski: 1) Pacjenci z PHP powinni być diagnozowani na podstawie typowych objawów klinicznych, a oznaczenie stężenia Ca 
przed zabiegami ortopedycznymi jest konieczne. 2) W każdym przypadku PHP należy oznaczyć Ca, P, PTH w surowicy oraz wyklu-
czyć zespoły MEN 1 i MEN 2A. 3) Pacjenci z PHP wymagają diagnostyki wielonarządowych powikłań hiperkalcemii. 4) Po operacji 
gruczolaka przytarczyc niezbędna jest długoterminowa opieka endokrynologiczna.
Key words: 
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Figure 1. 3D rendering of the CT scan, a single lytic focus in 
the inferior-anterior zone of the left iliac, 22 × 12 × 25 mm in 
size, joint space narrowing involving both hip joints, soft tissue 
thickening and exudation in the hip joints
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(Fig. 4). Spine densitometry (DEXA Hologic) showed decreased 
bone mineral density (z-score – 1.9 SD), while scintiscan of the 
neck SPECT/CT (Technetium 99mTc sestamibi) demonstrated an 
enhanced uptake in the inferior left parathyroid gland. Due to 
severe hypercalcemia, the boy was urgently admitted to the En-
docrinology Ward, University Children’s Hospital of Cracow. His 
general condition was good. On admission, he presented with 
an elevated calcium value (Ca – 4.00 mmol/l), hypophospha-
temia (P – 0.84 mmol/l), hypomagnesemia (Mg – 0.59 mmol/l; 
N: 0.6–0.95) and vitamin D3 deficit (25(OH)D3: 7.2 ng/ml (N: 
20–60). His TRP = 88% was normal (N: 85–95%), 24-hour urine 
showed marked hypercalciuria (Ca – 0.32 mmol/kg/d), abdomi-
nal ultrasound was normal. ECG demonstrated shortened ST 
and QTc = 0.34 intervals typical for hypercalcemia. No patho-
logical lesions were detected by computed tomography of the 
head and hypothalamus and ophthalmologic examinations.
Initially, forced diuresis and loop diuretics were employed, 
yet the expected reduction of calcemia did not occur. Subse-
quently, pamidronic acid was added (two intravenous doses 
of 30 mg) and the effect was good. During pamidronic acid in-
fusions, the patient presented transient flu-like symptoms with 
fever and leucopenia. Phosphate deficits were treated with oral 
phosphate mixture; magnesium and vitamin D3 supplementa-
tion was also introduced, resulting in a gradual normalization of 
serum electrolytes after 8 days of treatment. 
Diagnostic tests to exclude MEN 1 and MEN 2A syndromes 
(Multiple Endocrine Neoplasia) were performed: serum A 
chromogranin, calcitonin and gastrin levels and 24-hour urine 
catecholamine metabolite values were normal. The thyroidal, 
adrenal and gonadal axis function was within the norm, simi-
larly as prolactin concentration levels. Gastrological diagnostic 
management including endoscopy ruled out abnormalities that 
might have corresponded to complications of hyperparathy-
roidism or MEN syndrome. The analysis of chromosome 11q13 
region excluded mutations of the MEN1 gene. 
The child was referred to the Department of Endocrinological 
Surgery, Third Chair of Surgery, Jagiellonian University Medical 
College, where the left inferior parathyroid gland was resected. 
Histopathology confirmed the presence of an adenoma. Com-
plete normalization of calcium, phosphates and PTH concen-
tration values was achieved. The child continues to be treated 
as an outpatient: his serum electrolytes are tested; phosphate 
supplementation has been gradually reduced and he continues 
to take vitamin D and calcium preparations. The boy moves ef-
ficiently, without crutches, and experiences no pain. 
Discussion
In view of its low incidence and non-specific course, estab-
lishing the diagnosis of PHP in children may be markedly de-
layed or even not taken into consideration in therapeutic man-
Figure 3. 15-year old patient with parathyroid adenoma after 
surgery due to bilateral slipped capital femoral epyphysis 
Figure 4. Ultrasound examination of the neck – hyperechogenic 
area measuring 1.5 × 2.05 cm in the inferior left thyroid pole
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agement. The interval between the onset of symptoms and the 
diagnosis is usually 2 years. In this period, permanent organ 
lesions may develop, such as osteoporosis, kidney damage, 
peptic ulcers, pancreatitis or arterial hypertension that may 
persist in spite of resolving the cause of hypercalcemia  [3]. 
Numerous authors emphasize a considerable number of erro-
neous diagnoses and cases of treating abnormalities that are 
a consequence of undiagnosed hyperparathyroidism [3, 11]. 
In the above described boy, the pronouncedly elevated cal-
cium level, loss of body mass and dynamics of bone lesions 
suggested the diagnosis of PHP rather than juvenile bilateral 
slipped capital femoral epiphysis. Hypercalcemia, polyuria 
and polydipsia persisting for approximately 9 months (from 
the onset of symptoms to treatment initiation) did not result 
in other permanent organ lesions apart from bone complica-
tions. Another dangerous consequence of delayed diagno-
sis of hyperparathyroidism may be hypercalcemic crisis that 
is a  directly life-threatening condition. Described for the first 
time by Dawson and Struthers in 1923, it is characterized by 
severe hypercalcemia (Ca > 14 mg/dl or > 3.5 mmol/l) lead-
ing to symptoms of multiorgan failure [8]. Prior to the era of 
bisphosphonates, calcimimetics or plasmapheresis, hypercal-
cemic storm was an indication for surgical resection of parathy-
roid glands within 72 hours, with perioperative mortality rates 
of 14%. At present, therapeutic methods allow for normalizing 
plasma electrolytes before surgery and the incidence of hyper-
calcemic storm and surgical complications has decreased to 
2.8%. In addition, imaging studies (parathyroid scintiscan) and 
intraoperative PTH monitoring have increased the effectiveness 
of surgical treatment of parathyroid adenomas up to 92% [2]. 
Postoperatively, such patients, especially individuals with bone 
complications, require endocrinological treatment with calcium 
and vitamin D preparations due to the risk of hypocalcemia as-
sociated with the hungry bone syndrome [8]. Concentration 
values of calcium, phosphates, PTH and 25(OH)D3 should be 
monitored, similarly as renal function and bone density. In the 
pediatric population, almost one-half of cases of PHP has a ge-
netic background. Diffuse parathyroid hyperplasia with underly-
ing MEN 1 and MEN 2 syndromes and non-MEN associated 
familial hyperparathyroidism is much more common in children 
as compared to adults [3]. In case of multiple adenomas, es-
pecially in children, one should take into consideration genetic 
background of the lesions and an increased risk of relapses 
[9, 11, 12]. For this reason, despite negative family history, the 
presented patient underwent hormonal and genetic diagnostic 
tests aiming at ruling out MEN; follow-up determinations of Ca, 
P and PTH values are planned in his parents. 
Conclusions
1. Patients with parathyroid adenoma should be diagnosed/
suspected of the condition based on clinical symptoms of 
hypercalcemia, such as loss of appetite, nausea, consti-
pation, stomachache, polydipsia, polyuria, and most of all 
based on bone lesions. In patients with non-specific symp-
toms, it is necessary to determine serum Ca levels, espe-
cially prior to the planned surgical procedures.
2. In each case of PHP, determinations should be made of 
blood PTH, Ca and P and the patient should undergo com-
plete diagnostic hormonal and genetic management aim-
ing at detection of MEN 1 and MEN 2A syndromes. 
3. Patients with hyperparathyroidism require diagnostic man-
agement of multiorgan complications of hypercalcemia. 
4. Following surgical treatment of parathyroid adenoma, long-
term endocrinological follow-up is necessary in view of the 
risk of disorders of calcium phosphate metabolism, as well 
as the risk of hyperparathyroidism relapse. 
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